Education
About Us
Working with TipRanks
Follow Us
Talis Biomedical (TLIS)
OTHER OTC:TLIS
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 412.00K | $ 3.65M | $ 0.00 | $ 10.94M | $ 3.98M |
| Gross Profit | $ 371.00K | $ -4.74M | $ -2.62M | $ 10.94M | $ 3.98M |
| Operating Income | $ -66.81M | $ -115.14M | $ -191.82M | $ -91.18M | $ -26.70M |
| EBITDA | $ -66.05M | $ -106.31M | $ -191.82M | $ -90.42M | $ -25.97M |
| Net Income | $ -62.01M | $ -110.89M | $ -190.46M | $ -91.08M | $ -27.43M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 76.73M | $ 130.19M | $ 232.54M | $ 138.48M | $ 21.60M |
| Total Assets | $ 94.67M | $ 169.29M | $ 265.83M | $ 198.41M | $ 25.73M |
| Total Debt | $ 19.67M | $ 33.58M | $ 13.98M | $ 693.00K | $ 0.00 |
| Net Debt | $ -57.06M | $ -96.61M | $ -218.57M | $ -137.79M | $ -21.60M |
| Total Liabilities | $ 25.56M | $ 42.55M | $ 31.85M | $ 306.98M | $ 46.87M |
| Stockholders' Equity | $ 69.12M | $ 126.74M | $ 233.98M | $ -108.57M | $ -21.14M |
| Cash Flow | |||||
| Free Cash Flow | $ -53.73M | $ -101.75M | $ -174.25M | $ -95.22M | $ -24.90M |
| Operating Cash Flow | $ -53.24M | $ -100.14M | $ -171.38M | $ -87.02M | $ -24.33M |
| Investing Cash Flow | $ -486.00K | $ -1.61M | $ -2.87M | $ -8.20M | $ -578.00K |
| Financing Cash Flow | $ 33.00K | $ 406.00K | $ 234.43M | $ 246.75M | $ 39.61M |